Kymera Therapeutics Inc (NASDAQ: KYMR): Can A Stock Be 69.13% Higher Year-To-Date And Still Be A Loser?
Kymera Therapeutics Inc (NASDAQ:KYMR)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 2.23. At the close of